Skip to content
2000
Volume 14, Issue 3
  • ISSN: 0929-8665
  • E-ISSN: 1875-5305

Abstract

Investigations of the pathways involved in the metabolism of endocannabinoids have grown exponentially in recent years following the discovery of cannabinoid receptors (CB) and their endogenous ligands, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG). The in vivo biosynthesis of AEA has been shown to occur through several pathways mediated by N-acylphosphatidylethanolamide-phospholipase D (NAPE-PLD), a secretory PLA2 and PLC. 2- AG, a second endocannabinoid is generated through the action of selective enzymes such as phosphatidic acid phsophohydrolase, diacylglycerol lipase (DAGL), phosphoinositide-specific PLC (PI-PLC) and lyso-PLC. A putative membrane transporter or facilitated diffusion is involved in the cellular uptake or release of endocannabinoids. AEA is metabolized by fatty acid amidohydrolase (FAAH) and 2-AG is metabolized by both FAAH and monoacylglycerol lipase (MAGL). The author presents an integrative overview of current research on the enzymes involved in the metabolism of endocannabinoids and discusses possible therapeutic interventions for various diseases, including addiction.

Loading

Article metrics loading...

/content/journals/ppl/10.2174/092986607780090829
2007-03-01
2025-05-24
Loading full text...

Full text loading...

/content/journals/ppl/10.2174/092986607780090829
Loading

  • Article Type:
    Research Article
Keyword(s): alcohol-drinking behavior; CB1 receptors; CNS; Endocannabinoids; FAAH; MAGL; NAPE-PLD; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test